| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/09/2011 | US20110136870 Gacyclidine formulations |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136856 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 06/09/2011 | US20110136830 Chromenone derivatives |
| 06/09/2011 | US20110136828 Substituted n-oxide pyrazine derivatives |
| 06/09/2011 | US20110136807 Bicyclic compositions and methods for modulating a kinase cascade |
| 06/09/2011 | US20110136802 Ship1 modulators and methods related thereto |
| 06/09/2011 | US20110136794 Novel pyrrole derivative having, as substituents, ureido group, aminocarbonly group and bicyclic group which may have substituent |
| 06/09/2011 | US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110135756 Compositions and methods for protecting sensory hair cells |
| 06/09/2011 | US20110135752 Methods For Preserving Ophthalmic Solutions and Preserved Ophthalmic Solutions |
| 06/09/2011 | US20110135743 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 06/09/2011 | US20110135661 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135626 Localized Chemical Lysis of Ocular Tissue |
| 06/09/2011 | US20110135622 Presbyopia Treatment by Lens Alteration |
| 06/09/2011 | US20110135579 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 06/09/2011 | US20110135573 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 06/09/2011 | DE102009056597A1 Use of flavin derivatives and their salts for preparing a medicament for the treatment of pathologies of the internal limiting membrane (ILM), and the flavin derivative is riboflavin or roseoflavin |
| 06/09/2011 | CA2782727A1 2-pyridone compounds |
| 06/09/2011 | CA2781309A1 Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| 06/09/2011 | CA2781254A1 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 06/09/2011 | CA2780453A1 Treating xerophthalmia with compounds increasing meibomian gland secretion |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/08/2011 | EP2329835A1 Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
| 06/08/2011 | EP2329828A1 Tetracyclines for the treatment of ischaemia |
| 06/08/2011 | EP2329826A1 Tetracyclines for the treatment of multiple sclerosis |
| 06/08/2011 | EP2329821A1 Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema |
| 06/08/2011 | EP2329811A1 Ocular implant obtained by multiple extrusion process |
| 06/08/2011 | EP2328892A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 06/08/2011 | EP2328889A1 Acetyl pyrrolidinyl indole derivative |
| 06/08/2011 | EP2328577A1 The treatment of hearing loss |
| 06/08/2011 | EP2328574A1 Treatment of retinal degeneration |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1300407B2 Carbamates derived from arylalkylamines |
| 06/08/2011 | CN1997381B Corneal neuritogenesis promoter containing PACAP and its derivative |
| 06/08/2011 | CN1823838B Medicine and food dual purpose vitamin micro element mineral calcium nutritive product for preventing myopia and its manufacturing method |
| 06/08/2011 | CN1823837B Use of composition in preparing nutritire product for preventing and treating myopia |
| 06/08/2011 | CN102089306A Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds |
| 06/08/2011 | CN102089305A Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [3, 2, 1-iJ] quinoline compounds |
| 06/08/2011 | CN102089295A Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 06/08/2011 | CN102089285A Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102088978A Ameliorating or therapeutic agent for dyslipidemia |
| 06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
| 06/08/2011 | CN102085250A Goldthread root dispersible tablets |
| 06/08/2011 | CN102085240A Medicinal composition with effects of easing joint movement and opening orifices and preparation method thereof |
| 06/08/2011 | CN102085215A Use of first liquid and second liquid for preparing first combination and second combination for sequential use in the treatment of retinal tears and/or detachments of the retina |
| 06/08/2011 | CN102085203A Ophthalmic preparation of levofloxacin and prednisolone acetate and preparation method thereof |
| 06/08/2011 | CN102085175A Ophthalmic gel and preparation method thereof |
| 06/08/2011 | CN101337932B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
| 06/07/2011 | US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 06/07/2011 | US7956072 Agent for repairing corneal sensitivity containing amide compound |
| 06/07/2011 | US7956036 Polypeptide and DNA thereof useful as a neovascular marker |
| 06/07/2011 | CA2785233A1 .beta.-carbolines for treatment of hearing damages and vertigo |
| 06/03/2011 | WO2011065475A1 Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064508A1 Use of a dipyridyl compound for treating rosacea |
| 06/03/2011 | WO2011063606A1 Ophthalmic gel of gatifloxacin and preparation method thereof |
| 06/03/2011 | CA2782048A1 Use of a dipyridyl compound for treating rosacea |
| 06/03/2011 | CA2780650A1 Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method |
| 06/03/2011 | CA2776471A1 Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
| 06/02/2011 | US20110130457 Wax-Based Emulsion for the Treatment of Dry Eye Conditions |
| 06/02/2011 | US20110130451 Method of treating dry eye disorders and uveitis |
| 06/02/2011 | US20110130439 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 06/02/2011 | US20110130388 Prophylactic or therapeutic agent for axial myopia |
| 06/02/2011 | US20110130387 Sirtuin modulating compounds |
| 06/02/2011 | US20110130382 Modulators of 5-ht receptors and methods of use thereof |
| 06/02/2011 | US20110130376 New no releasing steroids derivatives |
| 06/02/2011 | US20110130375 New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 06/02/2011 | US20110130345 Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129516 Ocular drug delivery devices |
| 06/02/2011 | US20110129473 Vhnar anti-cytokine domains |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/01/2011 | EP2327699A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2327401A2 Retinoid Replacements and Opsin Agonists and Methods for the Use Thereof |
| 06/01/2011 | EP2327400A2 Retinoid Replacements and Opsin Agonists and Methods for the Use Thereof |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | EP2326623A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 06/01/2011 | EP2326342A1 Methods for using interferon gamma to absorb fluid from the subretinal space |
| 06/01/2011 | EP2326323A1 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 06/01/2011 | EP2114913B1 Thiophene derivatives useful as ocular hypotensive agents |
| 06/01/2011 | CN102083807A Therapeutic compounds |
| 06/01/2011 | CN102083434A Aqueous liquid containing gatifloxacin |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102078619A Transdermal therapeutic preparation |
| 06/01/2011 | CN102078614A Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078509A Traditional Chinese medicine preparation for treating ophthalmorrhagia and preparation method thereof |
| 06/01/2011 | CN102078480A Nano element traditional Chinese medicine negative ion far infrared electromagnetic wave-resistant life prolonging medicinal liquor |